Search Blog
December 2013
« Nov   Jan »


Top Gainers & Losers: InterOil Corporation, Geron Corporation,, ZIOPHARM Oncology Inc


By PrimeTimeMedia LLC

New York, December 06, 2013 /Accesswire/ – Market Buzz Report, a leading penny stock newsletters provider, issues major news alert for InterOil Corporation (USA)(NYSE:IOC), Geron Corporation(NASDAQ:GERN),, Inc.(NASDAQ:AMZN), ZIOPHARM Oncology Inc.(NASDAQ:ZIOP).

InterOil Corporation (USA)(NYSE:IOC) is halted after falling
21% premarket on news of the sale of a 61.3% stake in its Papua New Guinea gas
fields to Total (TOT) for as much as $3.6B, as the clarity of the deal is
questioned.The press release issued by IOC reads little like the one issued by
TOT: Total says depending on the results of the delineation of the Elk and
Antelope gas fields, “this could lead to a final investment decision by
2016 for the development of the fields and the construction of a liquefaction
plant located onshore on the Gulf of Papua.”

Free Urgent Insider Catalyst Report For IOC Available Here: (Or Copy and paste the URL into your browser)

Shares of Geron Corporation(NASDAQ:GERN) are up 9% in premarket trading.Behind the move looks to be an article outlining a Mayo Clinic study which says imetelstat “has been found to induce morphologic, molecular, and clinical remissions in some patients with myelofibrosis.”The study’s lead author calls the results “early but promising.”Amusingly, the article appears to have been posted ahead of its scheduled release from embargo.

Free Urgent Insider Catalyst Report For GERN Available Here: (Or Copy and paste the URL into your browser), Inc.(NASDAQ:AMZN) is set to significantly increase the fees it charges merchants for selling via its Webstore platform. As of Feb. 4, subscription fees will rise to $79/month for both merchants selling only on their site, and those selling both on their site and Amazon; they respectively paid $40/month and no subscription fee before. In addition, the transaction fee charged to the latter group will double to 2%.Amazon has already carried out a string of fee hikes for its on-site fulfillment services. But while merchants have griped, the hikes haven’t yet halted Amazon’s share gains against EBAY and other rivals. 3rd-party sales accounted for 40% of Amazon’s Q3 paid units, and are a relatively high-margin business. AllThingsD reports the AmazonFresh grocery delivery service could launch in San Francisco on Tuesday. AmazonFresh, which helps act as a foundation for Amazon’s same-day delivery efforts, launched in L.A. earlier this year, and might soon launch in NYC. No drones for now.

Free Urgent Insider Catalyst Report For AMZN Available Here: (Or Copy and paste the URL into your browser) 

ZIOPHARM Oncology Inc.(NASDAQ:ZIOP) gets approval from the RAC to run a Phase 1 study of Ad-RTS-IL-12 in brain cancer.The company expects to launch the study in H1 of next year.Ad-RTS-IL-12 is in Phase 2 testing for melanoma and breast cancer. (PR)Reminder: Ad-RTS-IL-12 is developed with a controlled expression platform from Intrexon (XON). 

Free Urgent Insider Catalyst Report For ZIOP Available Here: (Or Copy and paste the URL into your browser) is an investment community that focuses on MicroCap Securities. is an authorative authentic Google News Site and Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at


Follow us on Facebook:
Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126 (SMS alerts are free, however data rates may apply, check your wireless plan for details.).